ARCHIVES

NIH Guidelines Define Eligible Research Using Stem Cells.

This article is from The Cancer Letter archive.

Vol. 26 No. 32 | September 8, 2000

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991

Anti-NCI Forces Fail to Raid $70 Million from Cancer Program

September 26, 1975

ASCO Selects Three Cities For Quality Of Care Study.

June 2, 2000

Virus Program Report On Scientific Activities

August 15, 1975

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014